Blog

This Is Why Investors Will Need to Learn a New Acronym: CRISPR – Motley Fool

This Is Why Investors Will Need to Learn a New Acronym: CRISPR
Motley Fool
In this Market Foolery segment, host Chris Hill and Motley Fool Rule Breakers' Aaron Bush talk about where genetic engineering is heading — which is out of the lab and toward really curing diseases. Yes, it's early days. But the potential for CRISPR

2017-07-17 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.